샘플 요청 목록

 카트 문의
시장보고서
상품코드
1737282

멀티플렉스 진단 시장

Multiplexed Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 382 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

멀티플렉스 진단 세계 시장은 2030년까지 286억 달러에 달할 전망

2024년에 136억 달러로 추정되는 멀티플렉스 진단 세계 시장은 2024년부터 2030년까지 CAGR 13.2%로 성장하여 2030년에는 286억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 기기 및 액세서리는 CAGR 11.0%를 기록하며 분석 기간 종료시에는 154억 달러에 달할 것으로 예측됩니다. 키트 및 시약 부문의 성장률은 분석 기간 CAGR로 16.1%로 추정됩니다.

미국 시장은 37억 달러로 추정·중국은 CAGR 17.3%로 성장 예측

미국의 멀티플렉스 진단 시장은 2024년에 37억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 60억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 17.3%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 9.8%와 11.6%로 예측됩니다. 유럽에서는 독일이 CAGR 10.4%로 성장할 것으로 예측됩니다.

세계의 멀티플렉스 진단 시장 - 주요 동향과 촉진요인 정리

멀티플렉스 진단이 임상 및 POC 검사에서 주목받는 이유

멀티플렉스 진단은 하나의 생물학적 샘플에서 단백질, 핵산, 병원체 등 여러 분석물을 동시에 검출할 수 있는 분석 플랫폼을 말합니다. 이 접근법은 진단 효율을 크게 향상시키고, 시간을 단축하고, 샘플 양을 절약하기 때문에 감염 검사, 종양학, 자가면역질환 검사, 약리유전체학에서 점점 더 매력적으로 여겨지고 있습니다. 더 빠르고, 더 포괄적이며, 덜 침습적인 검사에 대한 수요가 증가함에 따라, 다중화 기술은 중앙 집중식 실험실과 분산형 POC(Point-of-Care) 모두에서 핵심적인 역할을 하고 있습니다.

기존의 단일 분석 항목 검사에 비해 멀티플렉스 분석은 진단 수율을 향상시키고 병태의 여러 원인을 동시에 검사하는 증후군 검사 접근법을 지원합니다. 예를 들어, 호흡기 멀티플렉스 패널은 인플루엔자, SARS-CoV-2, RSV 및 기타 병원체를 동시에 검출할 수 있어 실시간으로 치료 방침을 결정할 수 있습니다. 이는 전염병이 유행할 때나 면역력이 약한 환자 집단에서 특히 유용합니다. 의료 시스템이 정밀의료와 가치 기반 진료 모델로 전환하는 가운데, 멀티플렉스 진단은 더 많은 데이터를 더 낮은 검사 비용으로 더 빠른 임상적 판단 주기로 제공할 수 있는 수단을 제공합니다.

기술의 발전은 어떻게 다중화 능력과 임상적 유용성을 향상시키고 있는가?

마이크로유체공학, 바이오센서 소형화, 랩온칩 플랫폼, 디지털 검출 기술의 혁신은 루미넥스 비드 기반 시스템, PCR 마이크로어레이, 차세대 시퀀싱(NGS), 전기화학 바이오센서는 고감도, 고특이도, 고처리량의 멀티플렉스 분석이 가능합니다. 전기화학 바이오센서는 고감도, 특이성, 고처리량의 멀티플렉스 분석을 가능하게 합니다. 이러한 플랫폼은 현재 벤치탑 분석기, POC 카트리지 또는 웨어러블 디바이스에 통합할 수 있으며, 기존 실험실 환경 외에도 다양한 용도로 활용되고 있습니다.

바코드화된 프로브 패널 및 다중화된 ELISA 포맷과 같은 디지털 다중화 기술은 한 번의 검사로 검출할 수 있는 표적의 수를 확장하고 있으며, CRISPR 기반 진단법 및 등온증폭법은 저비용으로 현장 배치가 가능한 다중화 플랫폼을 가능하게 하고 있습니다. 동시에 AI 알고리즘과 클라우드 기반 분석이 진단 워크플로우에 통합되어 복잡한 다중 다중화 데이터를 해석하고 실용적인 인사이트를 지원하고 있습니다. 자동화, 소형화, 스마트 커넥티비티는 진료소, 응급실, 가정 내 진단에 적합한 휴대용, 사용자 친화적인 멀티플렉스 검사 시스템으로의 전환을 촉진하고 있습니다.

멀티플렉스 진단에 대한 수요를 주도하는 질환 영역과 헬스케어 모델은?

감염성 질환은 여전히 주요 응용 분야로 호흡기 감염, 성병(STI), 소화기 질환, 패혈증 관련 병원체 식별에 멀티플렉스 패널이 널리 사용되고 있습니다. 종양학은 새로운 초점이며, 멀티플렉스 분석은 여러 유전자 변화 및 바이오마커의 동시 검출이 필요한 돌연변이 프로파일링, 동반진단, 액체 생검 애플리케이션에 사용되고 있습니다. 자가면역 및 알레르기 진단도 여러 항체 및 사이토카인 프로파일을 측정하는 다중화 면역분석의 혜택을 누리고 있습니다.

병원, 임상 검사실, 참조 실험실, 응급의료센터는 워크플로우 통합과 신속한 진단의 필요성으로 인해 멀티플렉스 진단의 주요 기관 사용자로 자리 잡았습니다. 또한, 소매 클리닉, 원격의료 네트워크, 이동식 의료 유닛을 통한 분산형 검사의 부상으로 최소한의 기술 교육으로 운영할 수 있는 소형 멀티플렉스 시스템에 대한 수요가 증가하고 있습니다. 중저소득 국가에서는 인프라의 제약이 있는 상황에서 진단 범위를 확장할 수 있는 비용 효율적인 방법으로 신드롬 멀티플렉스 플랫폼을 모색하고 있습니다.

멀티플렉스 진단 시장의 장기적인 성장과 혁신의 원동력은 무엇인가?

멀티플렉스 진단 시장의 성장은 질병의 복잡성과 공중보건 감시의 필요성이 증가함에 따라 신속하고 처리량이 높으며 종합적인 진단 솔루션에 대한 세계 수요에 의해 주도되고 있습니다. 발병 대비, 항균제 관리, 종양학 개별화, 다중 다중 분석의 채택을 가속화하기 위해 협력하고 있습니다. 증후군 검사 패널에 대한 규제 당국의 지원과 고급 진단 도구에 대한 보험 환급 적용도 시장 실행 가능성을 높이고 있습니다.

개발업체들은 패널 컨텐츠의 확장, 검체 처리 자동화 개선, 시설의 워크플로우에 맞춘 모듈식 플랫폼 개발에 투자하고 있습니다. 진단약 기업, 생명공학 기업, 의료 서비스 제공자 간의 전략적 파트너십은 진단과 치료를 통합하는 플랫폼의 공동 개발을 촉진하고 있습니다. 또한, 실시간 질병 모니터링, 원격지용 휴대용 멀티플렉스 기기, 디지털 헬스와의 통합을 통해 이러한 기술의 임상적 유용성이 확대되고 있습니다.

헬스케어가 점점 더 데이터 중심적이고 환자 중심적으로 변화함에 따라, 멀티플렉스 진단은 조기 발견, 맞춤형 치료, 시스템 전반의 효율성 향상에 필수적인 역할을 하며, 세계 헬스케어 생태계에서 진단의 미래를 결정짓는 역할을 할 것입니다.

부문

제품 유형(기기 및 액세서리, 키트 및 시약), 용도(감염증, 종양학, 자가면역질환, 심장질환, 알레르기, 기타 용도), 최종사용자(병원, 진단 센터, 기타 최종사용자)

조사 대상 기업 사례(총 43개사)

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • BioFire Diagnostics
  • BioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Co-Diagnostics, Inc.
  • DiaSorin S.p.A.
  • Exact Sciences Corporation
  • Hologic, Inc.
  • Illumina, Inc.
  • Luminex Corporation
  • NanoString Technologies, Inc.
  • QIAGEN N.V.
  • QuidelOrtho Corporation
  • Randox Laboratories
  • Roche Diagnostics
  • Seegene Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 인위적인 매출원가 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

Global Industry Analysts는 세계 주요 수석 이코노미스트(1,4,949명), 싱크탱크(62개 기관), 무역 및 산업 단체(171개 기관)의 전문가들의 의견을 면밀히 검토하여 생태계에 미치는 영향을 평가하고 새로운 시장 현실에 대응하고 있습니다. 모든 주요 국가의 전문가와 경제학자들이 관세와 그것이 자국에 미치는 영향에 대한 의견을 추적 조사하고 있습니다.

Global Industry Analysts는 이러한 혼란이 향후 2-3개월 내에 마무리되고 새로운 세계 질서가 보다 명확하게 확립될 것으로 예상하고 있으며, Global Industry Analysts는 이러한 상황을 실시간으로 추적하고 있습니다.

2025년 4월 : 협상 단계

이번 4월 보고서에서는 관세가 세계 시장 전체에 미치는 영향과 지역별 시장 조정에 대해 소개합니다. 당사의 예측은 과거 데이터와 진화하는 시장 영향요인을 기반으로 합니다.

2025년 7월 : 최종 관세 재설정

고객님들께는 각 국가별 최종 리셋이 발표된 후 7월에 무료 업데이트 버전을 제공해 드립니다. 최종 업데이트 버전에는 명확하게 정의된 관세 영향 분석이 포함되어 있습니다.

상호 및 양자 간 무역과 관세의 영향 분석:

미국 <> 중국 <> 멕시코 <> 캐나다 <> EU <> 일본 <> 인도 <> 기타 176개국

업계 최고의 이코노미스트 : Global Industry Analysts의 지식 기반은 국가, 싱크탱크, 무역 및 산업 단체, 대기업, 그리고 세계 계량 경제 상황의 전례 없는 패러다임 전환의 영향을 공유하는 분야별 전문가 등 가장 영향력 있는 수석 이코노미스트 그룹을 포함한 14,949명의 이코노미스트를 추적하고 있습니다. 16,491개 이상의 보고서 대부분에 마일스톤에 기반한 2단계 출시 일정을 적용하고 있습니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.06.12

Global Multiplexed Diagnostics Market to Reach US$28.6 Billion by 2030

The global market for Multiplexed Diagnostics estimated at US$13.6 Billion in the year 2024, is expected to reach US$28.6 Billion by 2030, growing at a CAGR of 13.2% over the analysis period 2024-2030. Instruments & Accessories, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$15.4 Billion by the end of the analysis period. Growth in the Kits & Reagents segment is estimated at 16.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 17.3% CAGR

The Multiplexed Diagnostics market in the U.S. is estimated at US$3.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.0 Billion by the year 2030 trailing a CAGR of 17.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.8% and 11.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.4% CAGR.

Global Multiplexed Diagnostics Market - Key Trends & Drivers Summarized

Why Is Multiplexed Diagnostics Gaining Prominence in Clinical Laboratories and Point-of-Care Testing?

Multiplexed diagnostics refers to analytical platforms capable of simultaneously detecting multiple analytes-such as proteins, nucleic acids, or pathogens-from a single biological sample. This approach significantly improves diagnostic efficiency, reduces turnaround time, and conserves sample volume, making it increasingly attractive for use in infectious disease testing, oncology, autoimmune disorder screening, and pharmacogenomics. With rising demand for faster, more comprehensive, and minimally invasive testing, multiplexing technologies are becoming central to both centralized laboratories and decentralized point-of-care (POC) settings.

Compared to traditional single-analyte tests, multiplex assays enhance diagnostic yield and support syndromic testing approaches where multiple causes of a condition are investigated in parallel. For example, respiratory multiplex panels can concurrently detect influenza, SARS-CoV-2, RSV, and other pathogens-guiding treatment decisions in real time. This is particularly valuable during epidemics or in immunocompromised patient populations. As healthcare systems transition toward precision medicine and value-based care models, multiplexed diagnostics provide a means to deliver richer data at lower per-test costs and faster clinical decision cycles.

How Are Technological Advancements Enhancing Multiplexing Capabilities and Clinical Utility?

Innovations in microfluidics, biosensor miniaturization, lab-on-chip platforms, and digital detection technologies are revolutionizing the performance and accessibility of multiplexed diagnostics. Luminex bead-based systems, PCR microarrays, next-generation sequencing (NGS), and electrochemical biosensors are enabling multiplex assays with high sensitivity, specificity, and throughput. These platforms can now be integrated into benchtop analyzers, POC cartridges, or wearable devices-extending their use beyond traditional laboratory environments.

Digital multiplexing techniques, such as barcoded probe panels and multiplexed ELISA formats, are expanding the number of targets that can be detected in a single run. CRISPR-based diagnostics and isothermal amplification methods are enabling low-cost, field-deployable multiplex platforms. Simultaneously, AI algorithms and cloud-based analytics are being integrated into diagnostic workflows to interpret complex multiplex data and support actionable insights. Automation, miniaturization, and smart connectivity are driving a shift toward portable, user-friendly multiplex testing systems suitable for clinics, emergency settings, and even home diagnostics.

Which Disease Areas and Healthcare Models Are Driving Demand for Multiplexed Diagnostics?

Infectious diseases remain the dominant application area, with multiplex panels used extensively for respiratory infections, sexually transmitted infections (STIs), gastrointestinal diseases, and sepsis-related pathogen identification. Oncology is an emerging focus, where multiplexed assays are used for mutation profiling, companion diagnostics, and liquid biopsy applications that require the simultaneous detection of multiple gene alterations or biomarkers. Autoimmune and allergy diagnostics are also benefiting from multiplexed immunoassays that measure multiple antibody or cytokine profiles.

Hospitals, clinical laboratories, reference labs, and urgent care centers are the key institutional users of multiplex diagnostics, driven by the need for workflow consolidation and faster diagnostic turnaround. Additionally, the rise of decentralized testing through retail health clinics, telemedicine networks, and mobile health units is creating demand for compact multiplex systems that can be operated with minimal technical training. Low- and middle-income countries are exploring syndromic multiplex platforms as a cost-effective way to expand diagnostic reach amid infrastructure constraints.

What Is Driving Long-Term Growth and Innovation in the Multiplexed Diagnostics Market?

The growth in the multiplexed diagnostics market is driven by the global demand for rapid, high-throughput, and comprehensive diagnostic solutions amid increasing disease complexity and public health surveillance needs. Outbreak preparedness, antimicrobial stewardship, and oncology personalization are aligning to accelerate the adoption of multiplex assays. Regulatory support for syndromic testing panels and reimbursement coverage for advanced diagnostic tools are also reinforcing market viability.

Manufacturers are investing in expanding panel content, improving sample processing automation, and developing modular platforms that can be tailored to institutional workflows. Strategic partnerships between diagnostic firms, biotech companies, and healthcare providers are driving co-development of integrated diagnostic-treatment platforms. Additionally, real-time disease monitoring, portable multiplex devices for remote settings, and digital health integration are extending the clinical utility of these technologies.

As healthcare delivery becomes increasingly data-driven and patient-centric, multiplexed diagnostics will serve as an essential enabler of early detection, personalized therapy, and system-wide efficiency-defining the future of diagnostics across global healthcare ecosystems.

SCOPE OF STUDY:

The report analyzes the Multiplexed Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Instruments & Accessories, Kits & Reagents); Application (Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies, Other Applications); End-User (Hospitals, Diagnostic Centers, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • BioFire Diagnostics
  • BioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Co-Diagnostics, Inc.
  • DiaSorin S.p.A.
  • Exact Sciences Corporation
  • Hologic, Inc.
  • Illumina, Inc.
  • Luminex Corporation
  • NanoString Technologies, Inc.
  • QIAGEN N.V.
  • QuidelOrtho Corporation
  • Randox Laboratories
  • Roche Diagnostics
  • Seegene Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Multiplexed Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for High-Throughput Testing in Infectious Disease Panels Drives Adoption of Multiplexed Diagnostics
    • Expansion of Syndromic Testing Platforms Throws the Spotlight on Multi-Analyte Diagnostic Capabilities
    • Growth in Point-of-Care and Near-Patient Testing Fuels Use of Compact Multiplex Systems
    • Advancements in Microfluidics and Lab-on-Chip Technologies Propel Miniaturization and Portability
    • Increased Integration of AI and Data Analytics Enhances Interpretation of Complex Diagnostic Profiles
    • Surge in Oncology Biomarker Panels Spurs Innovation in Multi-Gene Expression Assays
    • Widespread Adoption in Respiratory Virus Detection Strengthens Market for Flu-COVID-RSV Panels
    • Regulatory Support for Panel-Based Diagnostics Accelerates Approvals in Infectious Disease Management
    • Focus on Personalized Medicine Drives Development of Targeted Multiplex Companion Diagnostics
    • Use of Multiplex PCR and Next-Generation Sequencing Expands Platform Versatility Across Indications
    • Demand for Cost-Effective Testing in Resource-Limited Settings Spurs Adoption of Multiplex Formats
    • Growth in Antibiotic Stewardship Programs Strengthens Relevance of Rapid Pathogen Identification Panels
    • Increased Use in Transplant, Sepsis, and Autoimmune Disease Diagnostics Broadens Clinical Utility
    • Collaborations Between Diagnostic Firms and Pharma Companies Enhance Drug-Response Testing Capabilities
    • Decentralization of Diagnostic Workflows Supports Integration in Ambulatory and Rural Healthcare Settings
    • Development of Multiplex Immunoassays and Serological Panels Expands Role in Surveillance Programs
    • OEM Investment in Automation and Workflow Integration Improves Lab Efficiency and Throughput
    • Focus on Panel Flexibility and Modular Testing Drives Customization for Niche Clinical Needs
    • Emergence of Home-Based and Self-Collection Multiplex Kits Expands Consumer Access and Monitoring
    • Increased Pandemic Preparedness Investments Sustain Demand for Scalable, Rapid Multi-Pathogen Detection
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Multiplexed Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Multiplexed Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Multiplexed Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Instruments & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Instruments & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Instruments & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Infectious Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Autoimmune Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Cardiac Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Cardiac Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Cardiac Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Allergies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Allergies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Allergies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Multiplexed Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Multiplexed Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Multiplexed Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Multiplexed Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Multiplexed Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Multiplexed Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Multiplexed Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제